Gara Jalqabaatti › Lipoid Nephrosis › Texas
Qorannoo klinikaalii Lipoid Nephrosis Texas keessatti
Qorannoo 4 Lipoid Nephrosis f Texas keessatti hirmaatuu jiru.
Magaalota Texas keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 16 hanga 75 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
- Clinical Advancement Center, San Antonio
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 80 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 17 · Saalaa hunda · Haaromfame 12-Cam-2026 · NCT05003986Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.